Afluria Quadrivalent (Seqirus)
Showing 1 - 25 of 297
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults
Recruiting
- Influenza
- +2 more
- Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)
- High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
-
Oakland, CaliforniaKaiser Permanente Northern California (entire region)
Sep 1, 2023
Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine
Not yet recruiting
- Influenza, Human
- ARCT-2138
- +2 more
-
Brisbane, Queensland, AustraliaNucleus Network Brisbane Clinic
Nov 8, 2023
Infertility Trial in New York (Influenza Vaccine, Sterile Saline)
Enrolling by invitation
- Infertility
- Influenza Vaccine
- Sterile Saline
-
New York, New YorkCenter For Human Reproduction
Mar 8, 2022
National Vaccine Adverse Event Reporting Survey and Etiology
Recruiting
- COVID-19
- +12 more
- vaccinated
-
Northglenn, ColoradoNeuroganics LLC
Mar 3, 2022
Respiratory Syncytial Virus Trial in United States (Placebo, mRNA-1345, Afluria® Quadrivalent)
Active, not recruiting
- Respiratory Syncytial Virus
- Placebo
- +3 more
-
Birmingham, Alabama
- +61 more
Dec 5, 2022
Afluria Pregnancy Registry
Completed
- Influenza, Human
- +2 more
- Afluria Influenza Vaccine
-
Wilmington, North CarolinaSyneos Health
Feb 7, 2022
Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)
Not yet recruiting
- Influenza, Human
- aQIV
- QIV
-
Batumi, Georgia
- +16 more
Oct 11, 2023
Influenza Trial in Lima (FLUAD Quadrivalent, FluQuadri)
Active, not recruiting
- Influenza
- FLUAD Quadrivalent
- FluQuadri
-
Lima, Peru
- +1 more
Sep 19, 2023
Influenza, Human Trial in Estonia, Germany, United States (aQIV, Comparator QIV)
Active, not recruiting
- Influenza, Human
- aQIV
- Comparator QIV
-
Mobile, Alabama
- +28 more
Jul 26, 2022
Influenza, Human Trial in United States (Experimental: IIV-A Investigational IIV-A will be administered as a single dose
Not yet recruiting
- Influenza, Human
- Experimental: IIV-A Investigational IIV-A will be administered as a single dose intramuscularly on Day 1
- +3 more
-
Tempe, Arizona
- +44 more
Aug 16, 2022
Influenza, Human Trial in United States (Investigational aIIV4c, IIV4c type 1, aIIV4)
Completed
- Influenza
- Human
- Investigational aIIV4c
- +3 more
-
Mobile, Alabama
- +20 more
Mar 15, 2022
Influenza, Human Trial in Worldwide (QIVc, Comparator)
Active, not recruiting
- Influenza, Human
- QIVc
- Comparator
-
Dobrich, Bulgaria
- +54 more
Jan 17, 2023
Influenza Trial in Portland, Temple (Flublok, Flucelvax, Fluarix)
Completed
- Influenza
- Flublok
- +4 more
-
Portland, Oregon
- +1 more
Jul 26, 2022
Infertility, Recurrent Miscarriage Trial in New York (Influenza Vaccine, Sterile Saline)
Unknown status
- Infertility
- Recurrent Miscarriage
- Influenza Vaccine
- Sterile Saline
-
New York, New YorkCenter For Human Reproduction
Feb 15, 2020
Influenza, Human Trial (Investigational aQIVc, licensed QIV1, licensed QIV2)
Not yet recruiting
- Influenza, Human
- Investigational aQIVc
- +2 more
- (no location specified)
Aug 28, 2023
Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID
Not yet recruiting
- Influenza
- +3 more
- Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
- +2 more
-
Phoenix, Arizona
- +7 more
Aug 30, 2023
Quadrivalent Influenza Vaccine Immunization Schedule for
Completed
- GCP
- Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
-
Jinan, Shandong, ChinaKou Zengqiang
Oct 17, 2023
Influenza, Seasonal Influenza Trial run by the NIAID (VRC-FLUMOS0111-00-VP (FluMos-v1), Flucelvax)
Active, not recruiting
- Influenza
- Seasonal Influenza
- VRC-FLUMOS0111-00-VP (FluMos-v1)
- Flucelvax
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Influenza, Human Trial in Worldwide (QIVc, Non-influenza Comparator Vaccine)
Completed
- Influenza, Human
- QIVc
- Non-influenza Comparator Vaccine
-
Sherwood, Queensland, Australia
- +39 more
Oct 19, 2020
Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in
Suspended
- Influenza Vaccine Effectiveness
-
Gainesville, Florida
- +11 more
Jan 13, 2023
Influenza Trial in Raymond Terrace (OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Brand 1), Quadrivalent Inactivated
Not yet recruiting
- Influenza
- OVX836 480µg
- +3 more
-
Raymond Terrace, Brisbane, AustraliaMater Misericordiae University Hospital
Feb 9, 2023
Influenza Trial in Brookvale (OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Fluarix® Tetra), Placebo)
Completed
- Influenza
- OVX836 480µg
- +2 more
-
Brookvale, New South Wales, AustraliaNorthern Beaches Clinical Research
Dec 15, 2022
Influenza Immunization Trial in Puerto Rico, United States (Quadrivalent Influenza mRNA Vaccine MRT5413, Quadrivalent
Recruiting
- Influenza Immunization
- Quadrivalent Influenza mRNA Vaccine MRT5413
- +3 more
-
Long Beach, California
- +23 more
Jan 31, 2023